Introduction
Periampullary carcinomas are tumors developed near the ampulla of Vater. They include lesions originated from the ampulla of Vater, head and neck of the pancreas, distal common bile duct (CBD) and from the second part of the duodenum. Usually, periampullary tumors are diagnosed in advanced stages due to infiltration of local structures or disseminated disease. Malignant obstructive jaundice is the most common presentation and its management can be complex [1, 2] . In patients who do not qualify for surgical treatment, palliative biliary tract drainage must be considered as it improves quality of life and prevents associated complications, such as cholangitis, pruritus, nausea, and anorexia [3, 4] . The preferred procedure to relieve biliary obstruction is endoscopic retrograde cholangiopancreatography (ERCP) with stent placement, with a success rate of 90% [5] . However, in some situations, it is not possible to perform ERCP, for example, in cases of inaccessible papilla due to periampullary or duodenal tumor invasion [6] . In such circumstances, percutaneous transhepatic biliary drainage (PTBD) is conventionally the alternative procedure, but it is associated with substantial morbidity. Recently, interventional procedures using endoscopic ultrasound (EUS) have been developed as an alternative technique, namely EUS-guided choledochoduodenostomy (EUS-CD), a transduodenal approach for CBD drainage [6] [7] [8] .
Clinical Case
An 88-year-old female presented to the emergency department due to an episode of hematochezia, abdominal pain for the last 2 days, jaundice, and progressive asthenia. She had a past medical history of chronic renal disease, arterial hypertension, cardiac insufficiency, a cardiac pacemaker, and atrial fibrillation, medicated with oral anticoagulant. On admission, she was afebrile and hemodynamically stable. Laboratory tests revealed: hemoglobin 10 g/dL, leukocytes 10,740/mm 3 , normal C-reactive protein, aspartate transaminase 179 U/L, alanine transaminase 301 U/L, alkaline phosphatase 539 U/L, total bilirubin 7.2 mg/dL (conjugated bilirubin 6.0 mg/dL), serum creatinine 2.2 mg/dL, prolonged prothrombin time, and international normalized ratio. Transabdominal ultrasound and computed tomography demonstrated dilation of the intrahepatic biliary ducts, CBD and Wirsung. A periampullar mass was identified compressing the distal portion of the CBD and invading the second part of the duodenum. There were no metastatic lesions or vascular involvement and it was not possible to exclude peripancreatic lymphadenopathies. An upper endoscopy was performed revealing a deformed and stenotic transition from the bulb to the second portion of the duodenum. Distally, an apparent villous and friable tissue was visualized, which was difficult to assess. No other potential bleeding lesions were identified. The examination was interrupted due to patient intolerance. Coagulation status was corrected and the patient started taking enoxaparin. A colonoscopy was performed and lesions were excluded.
Further laboratory tests revealed a CA 19.9 level of 177.89 U/L that, in the presence of a periampullar mass with duodenal invasion, can be indicative of malignant CBD stenosis, despite the concomitant biliary obstruction. The patient experienced clinical deterioration with evidence of acute cholangitis and increasing of the total bilirubin level (18.6 mg/dL). Considering the clinical situation, age, and comorbidities of the patient, it was decided (together with the patient and her family) to perform a palliative biliary drainage. The duodenal deformation made it impossible to carry out ERCP; therefore, it was decided to perform EUS-CD.
Ribeiro/Azevedo/Caldeira/Sousa/Pereira/ Banhudo The EUS-CD was performed with a linear echoendoscope. Through a duodenal bulbar approach, with the echoendoscope placed upstream of the duodenal stenosis, a dilated CBD was identified, up to 20 mm, filled with anechoic material and some echogenic particles in suspension. An avascular path for needle introduction was determined with color Doppler. A 19-G needle was inserted into the CBD, followed by aspiration of 40 mL of darkcolored bile. A 0.035-inch diameter straight tip guidewire was introduced through the needle channel and advanced to the right branch of the intrahepatic bile duct, confirmed on fluoroscopy (Fig. 1) . The needle was removed and the guidewire was left in place allowing the introduction of a 10-Fr cystotome. Using this cystotome, a tract was made between the duodenal bulb and the CBD (Fig. 2 ). An abundant outflow of black bile through the fistula orifice was immediately observed (Fig. 3) . The cystotome was then removed and a self-expandable fully covered metal biliary stent, 60 × 10 mm, was placed in the bile duct under endoscopic and fluoroscopic guidance (Fig. 4) . The positioning of the stent was confirmed on fluoroscopy and with ultrasound. During the procedure, no complications occurred. The patient's acute cholangitis was resolved, with considerable decrease in the total bilirubin. It was decided to continue the administration of enoxaparin instead of oral anticoagulation. One week after discharge, the abdominal ultrasound confirmed the correct position of the biliary stent. However, 5 days later, she was readmitted due to hematemesis. Upper endoscopy revealed that the stent had migrated in the bulb and a massive duodenal blood clot was visible. It was possible to observe the choledochoduodenostomy ostium with circumferential ulceration with a small visible vessel and evidence of hemobilia (Fig. 5a, b) . Adrenalin injections followed by polidocanol injections were performed in the ulcerated areas. However, the patient experienced recurrent hemorrhage with the need for several red blood cell transfusions. In order to control the bleeding, it was necessary to perform embolization of the branch of the superior mesenteric artery that anastomoses with the gastroduodenal artery with polyvinyl alcohol foam embolization particles and microcoil embolization of the gastroduodenal artery. There were no more bleeding relapses. Abdominal ultrasound performed prior to discharge confirmed the patency of the duodenal CBD fistula (Fig. 6) .
The patient did not experience other episodes of acute cholangitis or increased bilirubin. Three months later, a palliative duodenal stent was placed due to gastrointestinal obstructive symptoms. Despite this episode, the patient remained clinically well for almost 6 months after the CBD palliative drainage, until she presented clinical deterioration and died of acute-onset chronic renal failure.
Discussion
In cases of malignant obstructive jaundice and when ERCP is not a possible procedure, endoscopic ultrasoundguided biliary drainage (EUS-BD) can be considered as a minimal invasive alternative to PTBD or surgical interventions [5, 8] . EUS-BD was described for the first time in 2001 by Giovannini [9] and since then multiple studies regarding the techniques, indications, safety, and efficacy have been published. Extrahepatic and intrahepatic routes may be used and biliary drainage may be achieved transmurally by an anterograde approach, bridging the bile duct stricture, or by a retrograde approach, using a transpapillary rendezvous maneuver. Therefore, the drainage route depends on the indication, obstruction level, and anatomical circumstances [5, 7, 10] . EUS-CD is an anterograde transduodenal approach for the drainage of the CBD [7] . This procedure has an overall weighted technical success rate of 93% and clinical success rate of 98% [5, 7] . The overall adverse event rate reported for EUS-CD is 16% [7] . Most adverse events are classified as mild to moderate and can be treated conservatively. They include pneumoperitoneum (the most frequent complication), infection (cholangitis, peritonitis, cholecystitis), bile leakage, bleeding, abdominal pain, perforation, and stent migration [7, 8] .
In this case report, the EUS-CD was the procedure of choice after taking into account the comorbidities of the patient, the obstructive process of the CBD and the EUS expertise of our department. Other interventional options, like the surgical approaches, are associated with a high frequency of adverse events and procedure-related mortality [5] . PTBD and EUS-CD have comparable efficiency; however, PTBD is associated with a higher rate of adverse events and a higher cost due to the need for more reinterventions [5, 7] . In fact, Khashab et al. [8] conclud- ed that in patients with distal biliary obstruction after failed ERCP successful biliary drainage was similar in EUS-CD and PTBD (86.4 vs. 92.2%, p = 0.40). Furthermore, they concluded that EUS-CD was associated with lower rates of adverse events compared to PTBD (15.7 vs. 80.4%) and that health care costs for PTBD were twice that of the EUS-BD group. Our patient experienced bleeding 3 weeks after the procedure. Bleeding is an expected adverse event related to EUS-CD. In this case, hemorrhage was associated with the stent migration and probably also with the periampullary tumor and facilitated by the anticoagulation therapy [7] . Concerning the types of stents, both plastic and self-expandable metal stents (SEMS) have been used for EUS-CD. There are no comparative studies between metallic and plastic stents in terms of the efficacy and safety. However, SEMS has some advantages, for example, a larger diameter, better visibility, higher flexibility, and a longer patency [5] . Stent migration is still a problem of the technique, even using SEMS. In fact, the lack of specific devices, like tailored stents with antimigration properties, is a current challenge for endosonographers who perform EUS-CD [8] . In this patient, despite the displacement of the SEMS, the duodenal CBD fistula remained patent, allowing the palliation of the obstructive jaundice. Therefore, despite the complications, we admitted a technical and clinical success of the EUS-CD.
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